Showing results (231-240 of 273) with videos related to

Sort By:
Pageof 28
Journal of the American Society for Mass Spectrometry|May 15, 2023
"Lab of the Future"─Today: Fully Automated System for High-Throughput Mass Spectrometry Analysis of BiotherapeuticsHans E Waldenmaier, Elsa Gorre, Michael L Poltash, et al.
The Journal of Clinical Investigation|June 17, 2010
The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in miceMatthew B Greenblatt, Jae-Hyuck Shim, Weiguo Zou, et al.
Journal of the Pediatric Infectious Diseases Society|May 26, 2023
A Randomized Controlled Trial to Compare Immunogenicity to Cell-Based Versus Live-Attenuated Influenza Vaccines in ChildrenKatherine V Williams, Zhu-Nan Li, Bo Zhai, et al.
Vaccine|December 25, 2021
A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adultsKatherine V Williams, Bo Zhai, John F Alcorn, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2010
Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR)Kunhong Xiao, Jinpeng Sun, Jihee Kim, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 21, 2022
Targeting mTORC2/HDAC3 Inhibits Stemness of Liver Cancer Cells Against Glutamine StarvationHui-Lu Zhang, Ping Chen, He-Xin Yan, et al.
Oncology Reports|January 3, 2020
Cryopreserved biopsy tissues of rectal cancer liver metastasis for assessment of anticancer drug response in vitro and in vivoYuan Zhang, Wei-Jian Huang, Qiu-Rui Yang, et al.
Molecular Cell|October 25, 2011
mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTORDaming Gao, Hiroyuki Inuzuka, Meng-Kwang Marcus Tan, et al.
Cancer Cell|August 17, 2010
Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligaseHiroyuki Inuzuka, Alan Tseng, Daming Gao, et al.
Complementary Therapies in Medicine|September 15, 2019
CONSORT extension for reporting N-of-1 trials for traditional Chinese medicine (CENT for TCM) : Recommendations, explanation and elaborationJiang Li, Jia-Yuan Hu, Jing-Bo Zhai, et al.
Pageof 28